| abstract |
Disclosed are compounds of general Formula (I) wherein R3 is phenyl substituted with one or more substituents chosen from C1-C6 alkyl, halo or -SO2(C1-C6 alkyl), the remaining substituents are as defined in the specification; or a pharmaceutically acceptable salt, hydrate, solvate, complex or prodrug thereof; which are useful in the treatment of diseases and conditions mediated by the action of PGD2 at the CRTH2 receptor such as allergic asthma and perennial allergic rhinitis. |